OFS Enterprise’s AbbVie ABBV Stock Holding History

OFS Enterprise’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Sell	1,253 -264	-17%	-$56.8K	0.08%	77
2026 Q1	$330K	Buy	+1,517	New	+$337K	0.1%	74

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OFS Enterprise's ABBV Position: Q2 2026 in Review

OFS Enterprise reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $56.8K and leaving 1,253 shares worth $315K. The position accounts for 0.08% of the portfolio, ranked #77.

OFS Enterprise first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. The position peaked at $330K in Q1 2026. 4,191 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

OFS Enterprise held 1,253 shares of AbbVie worth $315K as of Q2 2026.
OFS Enterprise sold 264 AbbVie shares in Q2 2026, an estimated $56.8K.
AbbVie made up 0.08% of OFS Enterprise's portfolio in Q2 2026, its #77 holding.
OFS Enterprise first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
OFS Enterprise's AbbVie position peaked at $330K in Q1 2026.
4,191 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OFS Enterprise's 13F filing for Q2 2026, filed 8 Jul 2026.